Litcius/Paper detail

Acetyl-11-keto-β-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-κB pathways in SJL/J mouse model of experimental autoimmune encephalomyelitis

Ahmed Nadeem, Sheikh F. Ahmad, Naif O. Al‐Harbi, Wedad S. Sarawi, Sabry M. Attia, Wael A. Alanazi, Khalid E. Ibrahim, Sary Alsanea, Saleh A. Alqarni, Ali S. Alfardan, Saleh A. Bakheet

2022International Immunopharmacology22 citationsDOI

Topics & Concepts

Experimental autoimmune encephalomyelitisDownregulation and upregulationInflammationCD11cNitrotyrosineImmunologyEncephalomyelitisMicrogliaNitric oxideNitric oxide synthaseChemistryPharmacologyMedicineMultiple sclerosisEndocrinologyBiochemistryPhenotypeGenePharmacological Effects of Medicinal PlantsNatural product bioactivities and synthesisPsoriasis: Treatment and Pathogenesis
Acetyl-11-keto-β-boswellic acid improves clinical symptoms through modulation of Nrf2 and NF-κB pathways in SJL/J mouse model of experimental autoimmune encephalomyelitis | Litcius